Skip to content
10-Q

Quarterly Report

Elevation Oncology, Inc.

0001558370-24-014521

← back to feed
Filed
Nov 6, 2024 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Nov 1, 2024 59.12M sh
Shares Diluted Q3 2024 · Sep 30, 2024 59.11M sh
Shares Diluted Q3 2024 · Sep 30, 2024 56.66M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 46.84M sh
Shares Diluted restated Q3 2024 · Sep 30, 2023 33.04M sh
Stock Repurchased Q3 2024 · Sep 30, 2024 $44K
Stock Repurchased Q3 2024 · Sep 30, 2023 $22K
Operating Cash Flow Q3 2024 · Sep 30, 2024 −$26.16M
Operating Cash Flow Q3 2024 · Sep 30, 2023 −$44M
Long Term Debt Q3 2024 · Sep 30, 2024 $31.02M
Long Term Debt Q3 2024 · Dec 31, 2023 $30.14M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $48.2M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $49.26M
Stockholders Equity Q3 2024 · Sep 30, 2024 $69.36M
Stockholders Equity Q3 2024 · Jun 30, 2024 $80.92M
Stockholders Equity Q3 2024 · Dec 31, 2023 $54.81M
Stockholders Equity Q3 2024 · Sep 30, 2023 $62.42M
Stockholders Equity Q3 2024 · Jun 30, 2023 $72.18M
Stockholders Equity Q3 2024 · Dec 31, 2022 $49.03M
Current Liabilities Q3 2024 · Sep 30, 2024 $5.93M
Current Liabilities Q3 2024 · Dec 31, 2023 $4.15M
Total Liabilities Q3 2024 · Sep 30, 2024 $36.95M
Total Liabilities Q3 2024 · Dec 31, 2023 $34.28M
Current Assets Q3 2024 · Sep 30, 2024 $105.32M
Current Assets Q3 2024 · Dec 31, 2023 $87.96M
Total Assets Q3 2024 · Sep 30, 2024 $106.3M
Total Assets Q3 2024 · Dec 31, 2023 $89.09M
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.22
Eps Diluted Q3 2024 · Sep 30, 2024 −$0.60
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$0.23
Eps Diluted restated Q3 2024 · Sep 30, 2023 −$1.14
Eps Basic Q3 2024 · Sep 30, 2024 −$0.22
Eps Basic Q3 2024 · Sep 30, 2024 −$0.60
Eps Basic restated Q3 2024 · Sep 30, 2023 −$0.23
Eps Basic restated Q3 2024 · Sep 30, 2023 −$1.14
Sga Expense Q3 2024 · Sep 30, 2024 $3.84M
Sga Expense Q3 2024 · Sep 30, 2024 $12.11M
Sga Expense Q3 2024 · Sep 30, 2023 $3.5M
Sga Expense Q3 2024 · Sep 30, 2023 $11.65M
Rd Expense Q3 2024 · Sep 30, 2024 $9.39M
Rd Expense Q3 2024 · Sep 30, 2024 $21.95M
Rd Expense Q3 2024 · Sep 30, 2023 $7.42M
Rd Expense Q3 2024 · Sep 30, 2023 $20.74M
Net Income Q3 2024 · Sep 30, 2024 −$12.88M
Net Income Q3 2024 · Sep 30, 2024 −$34.05M
Net Income Q3 2024 · Sep 30, 2023 −$10.64M
Net Income Q3 2024 · Sep 30, 2023 −$37.81M
Operating Income Q3 2024 · Sep 30, 2024 −$13.23M
Operating Income Q3 2024 · Sep 30, 2024 −$34.06M
Operating Income Q3 2024 · Sep 30, 2023 −$10.92M
Operating Income Q3 2024 · Sep 30, 2023 −$37.5M